Guangdong Hybribio Biotech Co.,Ltd. (300639.SZ)
CNY 6.43
(0.94%)
CNY 6.43
(0.94%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 327.23 Million | 1.3 Billion | 631.34 Million | 311.3 Million | 112.83 Million | 80.39 Million |
| Net Income | 140.47 Million | 1.8 Billion | 884.93 Million | 394.65 Million | 136.95 Million | 106.74 Million |
| Depreciation & Amortization | 192.32 Million | 178.89 Million | 87.3 Million | 50.04 Million | 41.2 Million | 30.76 Million |
| Deferred income taxes | -59.63 Million | -79.61 Million | 26.63 Million | 9.58 Million | -9.55 Million | 920.32 Thousand |
| Stock-based compensation | -3.64 Million | 6.16 Million | 7 Million | 788.67 Thousand | 2.42 Million | 5.24 Million |
| Change in working capital | 134.6 Million | -1.36 Billion | -382.66 Million | -163.12 Million | -76.26 Million | -68.15 Million |
| Other non-cash items | 180.95 Million | 762.42 Million | 8.12 Million | 19.35 Million | 18.06 Million | 11.03 Million |
| Investing Cash Flow | -292.85 Million | -604.74 Million | -503.34 Million | -1.18 Billion | 131.88 Million | -200.49 Million |
| Investments in PPE | -385.32 Million | -734.36 Million | -641.07 Million | -287.11 Million | -196.56 Million | -144.43 Million |
| Acquisitions | 17.74 Million | 13.72 Million | 2.83 Million | 294.03 Million | 200.21 Million | - |
| Investment purchases | -1.01 Billion | -2.54 Billion | -2.64 Billion | -2.15 Billion | -405 Million | -1.13 Billion |
| Sales/Maturities of investments | 1.09 Billion | 2.65 Billion | 2.77 Billion | 1.24 Billion | 729.79 Million | 1.07 Billion |
| Other Investing Activities | 100.1 Million | 2.37 | 3.5 Million | -287.11 Million | -196.56 Million | 495.47 Thousand |
| Financing Cash Flow | -294.39 Million | -219.4 Million | 8.49 Million | 1.01 Billion | -43.72 Million | -6.95 Million |
| Debt repayment | -68.02 Million | -253.73 Million | -172.27 Million | -6 Million | - | -9840.00 |
| Dividends payments | -150.89 Million | -101.93 Million | -69.82 Million | -42.46 Million | -44.25 Million | -45.5 Million |
| Common Stock Repurchased | -49.99 Million | -49.99 Million | -49.97 Million | -50.17 Million | -411.54 Thousand | -80.15 Million |
| Common Stock Issuance | - | 49.99 Million | 49.97 Million | 50.17 Million | - | - |
| Other Financing Activities | -9.53 Million | 148.61 Million | 256.85 Million | 1.06 Billion | 939.82 Thousand | 38.54 Million |
| Accounts receivables | 873.51 Million | -1.91 Billion | -648.08 Million | -275.72 Million | -71 Million | -1.68 Million |
| Accounts payables | -802.72 Million | 698.96 Million | 289.93 Million | 156.22 Million | 7.92 Million | -57.59 Million |
| Inventory | 52.37 Million | -63.36 Million | -51.15 Million | -53.2 Million | -3.61 Million | -9.79 Million |
| Other working capital | 11.43 Million | -79.61 Million | 26.63 Million | 9.58 Million | -9.55 Million | -58.36 Million |
| Cash at beginning of period | 1.02 Billion | 521.97 Million | 390.95 Million | 257.33 Million | 55.57 Million | 184.36 Million |
| Cash at end of period | 764.93 Million | 1.02 Billion | 521.97 Million | 390.95 Million | 257.33 Million | 55.57 Million |
| Capital Expenditure | -385.32 Million | -734.36 Million | -641.07 Million | -287.11 Million | -196.56 Million | -144.43 Million |
| Effect of forex changes on cash | 947.86 Thousand | 13.4 Million | -5.47 Million | -4.36 Million | 763.09 Thousand | -1.71 Million |
| Net cash flow / Change in cash | -259.84 Million | 498.46 Million | 131.01 Million | 133.62 Million | 201.75 Million | -128.78 Million |
| Free Cash Flow | -58.08 Million | 574.85 Million | -9.73 Million | 24.18 Million | -83.72 Million | -64.03 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -184.99 Million | -62.57 Million | -14.35 Million | 140.47 Million | -31.63 Million | 49.26 Million |
| Depreciation & Amortization | - | 42.92 Million | 42.92 Million | 192.32 Million | 48.85 Million | -74.86 Million |
| Deferred income taxes | - | - | - | -59.63 Million | - | 436.32 Million |
| Stock-based compensation | - | - | - | -3.64 Million | -3.64 Million | -172.71 Thousand |
| Change in working capital | - | - | - | 134.6 Million | 937.33 Million | -361.28 Million |
| Other non-cash items | 265.92 Million | 135.54 Million | -48.9 Million | 180.95 Million | 217.56 Million | 68.8 Million |
| Investing Cash Flow | 130.99 Million | 61.73 Million | -28.88 Million | -292.85 Million | -87.08 Million | -85.04 Million |
| Investments in PPE | -27.05 Million | -59.52 Million | -43.88 Million | -385.32 Million | -59.76 Million | -73.22 Million |
| Acquisitions | 82.00 | 99.77 Thousand | 2341.00 | 17.74 Million | 17.67 Million | 11.2 Thousand |
| Investment purchases | - | -1.00 | -285 Million | -1.01 Billion | -281.97 Million | -138.25 Million |
| Sales/Maturities of investments | 158.04 Million | 121.16 Million | 300 Million | 1.09 Billion | 236.98 Million | 126.42 Million |
| Other Investing Activities | - | 99.77 Thousand | 15.79 Million | 100.1 Million | -19.67 Million | 1.02 |
| Financing Cash Flow | -7.94 Million | -23.1 Million | -35.13 Million | -294.39 Million | -71.87 Million | -25.85 Million |
| Debt repayment | -20.81 Million | -24.5 Million | -1.61 Million | -68.02 Million | -55.96 Million | -33.68 Million |
| Dividends payments | - | -42.14 Million | -2.96 Million | -150.89 Million | -150.89 Million | -839.36 Thousand |
| Common Stock Repurchased | 33.11 Million | -33.11 Million | - | -49.99 Million | -49.99 Million | 49.99 Million |
| Common Stock Issuance | - | - | - | - | - | -49.99 Million |
| Other Financing Activities | -61.88 Million | -5.45 Million | -33.51 Million | -9.53 Million | 200.92 Million | 8.66 Million |
| Accounts receivables | - | - | - | 873.51 Million | 873.51 Million | -341.75 Million |
| Accounts payables | - | - | - | -802.72 Million | - | - |
| Inventory | - | - | - | 52.37 Million | 52.37 Million | -19.52 Million |
| Other working capital | - | - | - | 11.43 Million | 11.43 Million | 4.37 Million |
| Cash at beginning of period | 709.5 Million | 640.24 Million | 764.93 Million | 1.02 Billion | 788.45 Million | 775.74 Million |
| Cash at end of period | 905.9 Million | 709.5 Million | 640.24 Million | 764.93 Million | 764.93 Million | 788.45 Million |
| Capital Expenditure | -27.05 Million | -59.52 Million | -43.88 Million | -385.32 Million | -59.76 Million | -73.22 Million |
| Effect of forex changes on cash | - | 3.36 Million | 2.59 Million | 947.86 Thousand | -870.36 Thousand | 5.53 Million |
| Net cash flow / Change in cash | 196.4 Million | 69.25 Million | -124.69 Million | -259.84 Million | -23.52 Million | 12.7 Million |
| Free Cash Flow | 53.87 Million | -29.48 Million | -107.15 Million | -58.08 Million | 77.31 Million | 44.84 Million |
0A3O
000898
HTCMY
OFSS
9921
002342